Navigation Links
NeoGenomics Announces Results for the 3rd Quarter 2007
Date:11/14/2007

st and conference call to discuss these results later this morning at 11:00 AM EST. Interested investors should dial (877) 407-8035 (domestic) and (201) 689-8035 (international) at least five minutes prior to the call. A replay of the conference call will be available until 11:59 PM on November 28, 2007 and can be accessed by dialing (877) 660- 6853 (domestic) and (201) 612-7415 (international). The playback account number is 286 and the playback conference ID Number/PIN Number is 261161. The web-cast may be accessed under the Investor Relations section of our website at http://www.neogenomics.org or at the website of our Investor Relations firm, Hawk Associates, at http://www.hawkassociates.com/ngnmmore.aspx or at http://www.vcall.com/IC/CEPage.asp?ID=118989. An archive of the web-cast will be available until 11:59 PM EST on February 15, 2008.

About NeoGenomics, Inc.

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, hospitals and other reference laboratories throughout the United States. For additional information about NeoGenomics, visit http://www.neogenomics.org.

Interested parties can also access additional investor relations material from the American Microcap Institute at

SOURCE NeoGenomics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. NeoGenomics, Inc. Schedules its Q3 07 Earnings Conference Call For Wednesday, November 14, 2007 at 11:00 AM
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...srupt normal development, mouse study finds , ... few glasses of wine over a short period in early ...chers from the Medical College of Georgia. , T...affects one in 1,000 babies, include facial malfor...ye openings, and a short nose. Researchers are inv...
(Date:8/29/2008)...-FirstCall/ -- Landauer, Inc. (NYSE:,LDR) announce...ular,quarterly cash dividend of $0.50 per share fo...will be paid on October 3, 2008, to shareholders o... Landauer is the leading provider of analytical se... radiation exposure. For more than 50 years,the C...
(Date:8/29/2008)...Telemedicine Encounter Management Systems (TEMS) t... possible solution to national health care problem...WEB) August 29, 2008 -- If there has been any one ...Democratic National Convention it has been the par...lth care issues., , ,Our Democratic leadership rec...
(Date:8/28/2008)...ia led to daytime tiredness, symptoms of depressio... -- Older adults who live with and provide direct ...ve significantly worse sleep than other older adul... 31 caregivers and 102 noncaregivers, ages 60 to 8...t than non-caregivers and took about 10 minutes lo...
Breaking Medicine News(10 mins):Health News:Alcohol in Early Pregnancy May Prompt Fetal Cell Death 2Health News:AMD Global Telemedicine Inc. Invited to Attend Democratic National Convention 2Health News:Older Caregivers Prone to Worse Sleep Patterns 2
...on of The Anatomical Record has put together a col...injury repair in animals. Spinal cord injury affec...m with little hope of living a normal life. Howeve...be stem cells - primitive cells that can turn into...
...e British Medical Journal, older people taking vit...xpected. The researchers from Cambridge, UK, ident... in the community. They sent either one capsule of...ve years. They asked the participants to provide t...
... the DNA within our cells, which could lead to can...e that triggers a protective mechanism in the body...ly damaged cells to destroy themselves. The molecu...echanism, was discovered by researchers at the Ins...
...the knees, is a form of arthritis where one or mor...lved in in these type of joint problems is the los...luid that moisturizes the area. This fluid is call...jections are being given to humans since 1987, aft...
Other Medicine News:
(Date:8/27/2008)... Memorial Hospital one of 18 centers involved in 1...wire/ -- Results of a 10-year study,published in t...edicine,found that magnesium sulfate administered ...educed the risk of cerebral palsy by 50 percent. T...te (BEAM) trial was,conducted in 18 centers in the...
(Date:8/27/2008)...Phase 3 data, from BLISS-52 trial, expected by mid...6, expected by fall 2009 -, ROCKVILLE, Md., Aug. ..., Inc. (Nasdaq: HGSI ) today announced it has com...the second of two pivotal Phase 3,randomized clini...nts with,active systemic lupus erythematosus (SLE)...
(Date:8/26/2008)...ds most patients can drive safely six weeks follow...PRNewswire-USNewswire/ -- Six weeks following,buni...that they are able to,get back behind the wheel of... issue of The Journal of Bone and Joint Surgery ( ...rake time response in patients who underwent a,fir...
(Date:8/26/2008)...Aug. 26 /- Omeros Corporation today a...se 1/Phase 2 trial investigating,OMS103HP in arthr...ction,surgery. OMS103HP is an investigational drug...solution and is designed to improve postoperative,...n and allow patients an,earlier return to work. Th...
Breaking Medicine Technology:National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births 2National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6Braking After Bunion Surgery 2Braking After Bunion Surgery 3Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery 2Love and Diabetes 3A dLife Valentines Day Quiz Tests and Teaches Important Relationship Lessons for People With Diabetes 11380 1Love and Diabetes 3A dLife Valentines Day Quiz Tests and Teaches Important Relationship Lessons for People With Diabetes 11380 2Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 1Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 2Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 3Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 4Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 5Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 6Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 7Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 8Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 9Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 10Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 11Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 12Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 13Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 14Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 15Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 16Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 17Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 18Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 19Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 20Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 21Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 22Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 23Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 24Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 25Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 26Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 27Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 28Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 29e Smart 28R 29 Technologies Delivers Its New Super Smart Card 28TM 29 in South Korea 2161 1e Smart 28R 29 Technologies Delivers Its New Super Smart Card 28TM 29 in South Korea 2161 2American Heart Association Themed Issue Journal Report 3A Journal Edition Dedicated to Womens Unique Hypertension Issues 11371 1American Heart Association Themed Issue Journal Report 3A Journal Edition Dedicated to Womens Unique Hypertension Issues 11371 2American Heart Association Themed Issue Journal Report 3A Journal Edition Dedicated to Womens Unique Hypertension Issues 11371 3American Heart Association Themed Issue Journal Report 3A Journal Edition Dedicated to Womens Unique Hypertension Issues 11371 4American Heart Association Themed Issue Journal Report 3A Journal Edition Dedicated to Womens Unique Hypertension Issues 11371 5
...ELPHIA, June 05, 2007 /PRNewswire/ -- , Professor ... are disappointing and,misleading in that they dis...ly relevant to patients and physicians. Most,signi...o evidence,of any increase in cardiovascular death... , CONTACT: Professor Philip Home, (44) 778-525-17...
...d Achieves All Key Endpoints for Both Efficacy and...re-FirstCall/ --,Indevus Pharmaceuticals, Inc. tod...macokinetic trial for NEBIDO (testosterone,undecan...apy under,development for the treatment of male hy...chering Pharma AG, Germany. The data,from the rece...
Other Medicine Technology:Indevus Reports Positive Data From Phase III NEBIDO Trial 2Indevus Reports Positive Data From Phase III NEBIDO Trial 3Indevus Reports Positive Data From Phase III NEBIDO Trial 4Indevus Reports Positive Data From Phase III NEBIDO Trial 5Indevus Reports Positive Data From Phase III NEBIDO Trial 6
...or Digital Thermostat and Digital Display. , Exter...inum ends. , Interiorwhite anodized aluminum with...frigeration (134A). , Temperature range 0C to 10C...-place polyurethane high density cell insulation (...
...ratory system for pH and temperature measurements....d when used with a temperature probe (ATC) or a 3-...oint calibration with Auto-Find automatic buffer r...10.01 and 12.45) and Auto-Read for locking onto st...
... Detectors provide unmatched value and flexibility.... Capable of performing fluorescence, luminescence...t, the DTX Series can operate as standalone instru... Coulters Biomek Laboratory Automation Workstation...
...hput Screening (HTS), Analyst HT smoothes the tran...on modalities and assay performance of Analyst AD,..., time-resolved fluorescence, luminescence, absorb...otic environments, including those from Beckman Co...
Medicine Products: